glucagon-like peptide 1 receptor agonist (Crinetics Pharmaceuticals)

N/A

Report date: 2025/06/11 11:18:12
NME

Base Information

Drug Nameglucagon-like peptide 1 receptor agonist (Crinetics Pharmaceuticals)
Drug Alias Namediabetes/obesity therapeutic (Crinetics Pharmaceuticals)
ClassificationSmall molecules
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrinetics Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCrinetics Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A